Arcturus Therapeutics Holdings Inc

ARCT

Equity

ISIN null / Valor 48461643

NASDAQ (2025-12-19)

USD 6.53+1.56%

Arcturus Therapeutics Holdings Inc
UMushroom community rating:

3.44 12 votes No rating yet

NegativeNeutralPositive

About company

Arcturus Therapeutics Holdings Inc is a biopharmaceutical company that focuses on the development of RNA-based therapeutics for the treatment of various diseases.

Summarized from source with an LLMView SourceSector: Finance

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-56.0%1Y

-61.0%3Y

-93.4%5Y

Performance

109%1Y

86.8%3Y

103%5Y

Volatility

186 M

Market cap (USD)

1,718,676

Daily traded volume (Shares)

16.91 / 16.03

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

3.44

12 votes

Performance:

3.11

Innovation:

3.67

Society:

3.57

Nature:

3.43

Loic Lienard

Switzerland, 27 Oct 2025

Arcturus Therapeutics is a highly innovative biotech company focused on mRNA-based vaccines and treatments. Although still volatile and in early stages, it shows strong potential for long-term growth in the biotechnology and healthcare sectors.